home / stock / rna / rna articles
Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NY...
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Avidity Biosciences, Inc. (NASDAQ:RNA) ("Avid...
STAMFORD, Conn., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Avidity Biosciences, Inc. (NASDAQ:RNA) ("Avidity" or the ...
Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclose...
News, Short Squeeze, Breakout and More Instantly...
Avidity Biosciences Inc. Company Name:
RNA Stock Symbol:
NASDAQ Market:
Avidity Biosciences Inc. Website:
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.85% on the day to $45.95. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.65% on the day to $45.54. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
2024-07-14 04:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...